全文获取类型
收费全文 | 9174篇 |
免费 | 548篇 |
国内免费 | 171篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 194篇 |
妇产科学 | 87篇 |
基础医学 | 1445篇 |
口腔科学 | 154篇 |
临床医学 | 821篇 |
内科学 | 1996篇 |
皮肤病学 | 498篇 |
神经病学 | 638篇 |
特种医学 | 745篇 |
外科学 | 1058篇 |
综合类 | 46篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 335篇 |
眼科学 | 200篇 |
药学 | 862篇 |
中国医学 | 145篇 |
肿瘤学 | 540篇 |
出版年
2024年 | 7篇 |
2023年 | 75篇 |
2022年 | 244篇 |
2021年 | 349篇 |
2020年 | 182篇 |
2019年 | 234篇 |
2018年 | 295篇 |
2017年 | 235篇 |
2016年 | 323篇 |
2015年 | 413篇 |
2014年 | 524篇 |
2013年 | 506篇 |
2012年 | 795篇 |
2011年 | 781篇 |
2010年 | 423篇 |
2009年 | 390篇 |
2008年 | 510篇 |
2007年 | 472篇 |
2006年 | 350篇 |
2005年 | 392篇 |
2004年 | 276篇 |
2003年 | 231篇 |
2002年 | 230篇 |
2001年 | 183篇 |
2000年 | 189篇 |
1999年 | 141篇 |
1998年 | 99篇 |
1997年 | 62篇 |
1996年 | 94篇 |
1995年 | 59篇 |
1994年 | 72篇 |
1993年 | 64篇 |
1992年 | 49篇 |
1991年 | 54篇 |
1990年 | 54篇 |
1989年 | 76篇 |
1988年 | 61篇 |
1987年 | 64篇 |
1986年 | 50篇 |
1985年 | 51篇 |
1984年 | 26篇 |
1983年 | 16篇 |
1982年 | 16篇 |
1981年 | 31篇 |
1980年 | 33篇 |
1979年 | 21篇 |
1978年 | 16篇 |
1977年 | 24篇 |
1976年 | 10篇 |
1975年 | 10篇 |
排序方式: 共有9893条查询结果,搜索用时 15 毫秒
11.
Man Bok Jeong Kristina Narfström Shin Ae Park Je Min Chae Kang Moon Seo 《Documenta ophthalmologica. Advances in ophthalmology》2009,119(2):79-88
The objective of this study is to compare the effects of three different anesthetic combinations on the electroretinogram
in the same animals under similar laboratory conditions. Thiopental–isoflurane (TI), medetomidine–ketamine (MK), and xylazine–ketamine
(XK) were used on each of 12 healthy miniature schnauzer dogs (MS) with a period of at least 3 weeks in between subsequent
anesthesia protocols, using the Dog Standard Protocol. The scotopic ERGs consisted of scotopic low stimulus strength (S) responses
designated S1, S2, S3, S4, and S5, at 1, 5, 10, 15, and 20 min after dark adaptation, respectively, and scotopic standard
stimulus strength (S-ST) responses. The photopic ERGs consisted of a photopic single flash (P) response and 31 Hz flicker
(P-FL) responses. For S-ST (2.5 cd s/m2), the amplitude of the a-wave using TI was significantly lower than that using MK (adjusted P = 0.05) and XK (adjusted P = 0.03), and the implicit time of the a-wave was significantly shorter than that using MK (adjusted P = 0.04). For P (2.5 cd s/m2), the amplitude of the b-wave using XK was significantly higher than that using MK (adjusted P = 0.01). The implicit times of the b-wave using TI was significantly longer and shorter than that of MK for S1, S2 and P-FL
and for S4 and S-ST, respectively, and than that of XK for S2 and P-FL and for S5 and S-ST, respectively. The results of the
present study showed that TI affected both the amplitude and the implicit time of the a-wave for S-ST and the implicit time
of the b-wave relatively more so than was the case when using XK or MK. Therefore, it appears that either XK or MK could be
advantageous to use rather than TI for clinical studies. 相似文献
12.
Choe Seong Wook MD Cho Wan Ik MD Lee Chang Kyun MD † Seo Seong Jun MD 《Dermatologic surgery》2005,31(5):502-508
BACKGROUND: Masseteric muscle hypertrophy is an uncommon dition represented as a swelling of the masseter muscle. Recent reports have demonstrated the successful use of botulinum in the treatment of masseteric hypertrophy. OBJECTIVE: This study was a prospective trial to evaluate the effectiveness of botulinum toxin type A (Botox) in the treatment of masseteric muscle hypertrophy according to doses of 10, 20, and 30 U. MATERIALS AND METHODS: Twenty-two patients were referred to the dermatologic clinic for the management of masseteric muscle hypertrophy. Ultrasonographic measurements of the thickness of the masseter muscle were performed, and clinical photographs were taken before treatment and 1, 2, 3, 4, 6, and 9 months after the treatment. RESULTS. The median values of percentage reduction of muscle mass were 10.3%, 16.5%, 23.7%, 24.7%, 21.6%, 16.5% in the 10 U group; 11.9%, 18.8%, 24.8%, 27.7%, 26.7%, and 21.8% in the 20 U group; and 12.0%, 19.4%, 25.0%, 27.8%, 37.8%, and 24.1% in the 30 U group. CONCLUSION. The adequate dose of botulinum toxin type A for treatment of masseteric muscle hypertrophy should be above 20 U. The effect of botulinum toxin type A is maintained for at least 9 months as the treatment of masseteric muscle hypertrophy. 相似文献
13.
14.
15.
Jong-Moon Lee Kun-Woo Park Woo-Keun Seo Moon Ho Park Changsu Han Inho Jo Sangmee Ahn Jo 《Movement disorders》2007,22(16):2446-2449
There have been a few studies and inconsistent results regarding the coincidence of Parkinson's disease (PD) and atherosclerotic diseases, such as cerebrovascular disease. Carotid intima-media thickness (IMT) is a known marker for subclinical atherosclerosis. The aim of this study was to investigate the carotid IMT between PD patients and controls. We studied 43 patients with PD and 86 matched controls. The carotid IMT in PD patients was significantly smaller than in controls (0.796 +/- 0.179 mm vs. 0.913 +/- 0.237 mm, P < 0.05). In multivariate analysis, the carotid IMT was inversely associated with the duration of levodopa medication and the severity of PD. These results suggest that PD patients have a lower risk of atherosclerosis. 相似文献
16.
17.
18.
19.
Toshihiro Seo Taketoshi Kajihara Toshiro Iijima 《Macromolecular chemistry and physics.》1987,188(6):1295-1304
The catalytic hydrolysis of phenyl esters in systems containing ß-cyclodextrin (ß-CD) and polyelectrolytes was investigated. Poly(methacrylic acid) was found to exhibit an inhibition effect on the hydrolysis, while poly(sodium styrenesulfonate) (NaPSS) shows a pronounced acceleration effect on the hydrolysis: the larger the molecular weight and the lower the degree of substitution, the greater is the acceleration effect. On the other hand, sodium ethylbenzenesulfonate and sodium dodecylbenzenesulfonate inhibit the reaction. The acceleration of the reaction in presence of NaPSS is attributed to the concentration of ß-CD and the substrate esters near to the chain of the macromolecule, through inclusion effects and hydrophobic interactions. 相似文献
20.
K Kondo R Seo M Naka T Kitagawa K Wakitani M Sakata H Kira T Okegawa A Kawasaki 《European journal of pharmacology》1989,163(2-3):253-261
The beneficial effects of an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, 7-[2 alpha,4 alpha-(dimethylmethano)-6 beta-(2-cyclopentyl-2 beta- hydroxyacetamido)-1 alpha-cyclohexyl]-5(Z)-heptenoic acid (ONO-3708) on thrombosis were examined. ONO-3708 at 0.1-3 microM inhibited the human platelet aggregation induced by thromboxane A2, prostaglandin H2, collagen, ADP (secondary phase) and epinephrine (secondary phase) without affecting prostanoid synthesis and the content of cyclic AMP in platelets. The in vivo effects, on coronary thrombosis in this case, were examined in two canine models. ONO-3708, 3 to 300 micrograms/kg i.v., prevented dose dependently the coronary thrombosis induced by partial obstruction of the coronary artery. ONO-3708, 3 micrograms/kg per min i.v., significantly prevented electrically stimulated coronary thrombosis without affecting systemic blood pressure and heart rate. These results indicate that the thromboxane A2/prostaglandin endoperoxide receptor could play an important role in the pathogenesis of thrombosis and that ONO-3708 may have therapeutic advantages in preventing thrombosis. 相似文献